{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T13:28:01Z","timestamp":1760189281823,"version":"3.44.0"},"reference-count":19,"publisher":"BMJ","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["BMJ Case Reports"],"abstract":"<jats:p>A patient with a bulky inoperable stage IIIC melanoma involving the left axilla and neck from a primary of the left medial elbow received vemurafenib as neo-adjuvant treatment. Based on the molecular analysis, BRAF V600E mutation was present. After 4\u2005months of vemurafinib treatment, the tumours shrank to less than 50% of original clinical size and allowed the surgeons to perform a left modified radical neck dissection and left radical axillary dissection. Pathological analysis of specimen revealed viable metastatic cells only in 1 of 40 nodes resected in the neck and axillary dissection, accounting for over 98% pathological response. Other lymph nodes had a mixture of foamy histiocytic inflammatory reaction fibrosis and islands of necrotic tissues. After recovery from surgery, vemurafenib was resumed and continued for 6\u2005months. He remained disease free 6\u2005months after surgery.<\/jats:p>","DOI":"10.1136\/bcr-2012-007034","type":"journal-article","created":{"date-parts":[[2012,10,23]],"date-time":"2012-10-23T12:36:23Z","timestamp":1350995783000},"page":"bcr2012007034","source":"Crossref","is-referenced-by-count":7,"title":["Inoperable bulky melanoma responds to neoadjuvant therapy with vemurafenib"],"prefix":"10.1136","volume":"2012","author":[{"given":"Niloofar","family":"Fadaki","sequence":"first","affiliation":[{"name":"Department of Surgery, The Center for Melanoma Research and Treatment in California Pacific Medical Center, San Francisco, California, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Servando","family":"Cardona-Huerta","sequence":"additional","affiliation":[{"name":"Department of Surgery, The Center for Melanoma Research and Treatment in California Pacific Medical Center, San Francisco, California, USA"},{"name":"The Consorcio de UniversidadesMexicanas (CUMEX) and the Universidad Autonoma de Nuevo Leon, Mexico"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lea","family":"Martineau","sequence":"additional","affiliation":[{"name":"Department of Surgery, The Center for Melanoma Research and Treatment in California Pacific Medical Center, San Francisco, California, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Suresh","family":"Thummala","sequence":"additional","affiliation":[{"name":"Department of Surgery, The Center for Melanoma Research and Treatment in California Pacific Medical Center, San Francisco, California, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shih-Tsung","family":"Cheng","sequence":"additional","affiliation":[{"name":"Department of Dermatology, The Center for Melanoma Research and Treatment in California Pacific Medical Center, San Francisco, California, USA"},{"name":"Department of Dermatology, Faculty of Medicine, Kaohsiung Medical University, Taiwan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Steve R","family":"Bunker","sequence":"additional","affiliation":[{"name":"Department of Radiology, The Center for Melanoma Research and Treatment in California Pacific Medical Center, San Francisco, California, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard","family":"Garcia-Kennedy","sequence":"additional","affiliation":[{"name":"Department of Pathology, The Center for Melanoma Research and Treatment in California Pacific Medical Center, San Francisco, California, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Oncology, The Center for Melanoma Research and Treatment in California Pacific Medical Center, San Francisco, California, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Minor","sequence":"additional","affiliation":[{"name":"Department of Oncology, The Center for Melanoma Research and Treatment in California Pacific Medical Center, San Francisco, California, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammed","family":"Kashani-Sabet","sequence":"additional","affiliation":[{"name":"The Consorcio de UniversidadesMexicanas (CUMEX) and the Universidad Autonoma de Nuevo Leon, Mexico"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stanley P L","family":"Leong","sequence":"additional","affiliation":[{"name":"Department of Surgery, The Center for Melanoma Research and Treatment in California Pacific Medical Center, San Francisco, California, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2012,10,23]]},"reference":[{"key":"2025082723203970000_2012.oct22_1.bcr2012007034.1","first-page":"239","article-title":"Treatment options for limited or symptomatic metastatic melanoma. Cancer control","volume":"15","author":"McLoughlin","year":"2008","journal-title":"J Moffitt Cancer Center"},{"key":"2025082723203970000_2012.oct22_1.bcr2012007034.2","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(19821015)50:8<1656::AID-CNCR2820500833>3.0.CO;2-L"},{"key":"2025082723203970000_2012.oct22_1.bcr2012007034.3","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1097-0142(19970615)79:12<2345::AID-CNCR8>3.0.CO;2-K"},{"key":"2025082723203970000_2012.oct22_1.bcr2012007034.4","doi-asserted-by":"publisher","DOI":"10.1097\/00001622-200403000-00013"},{"key":"2025082723203970000_2012.oct22_1.bcr2012007034.5","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1103782"},{"key":"2025082723203970000_2012.oct22_1.bcr2012007034.6","doi-asserted-by":"publisher","DOI":"10.1016\/j.molonc.2007.12.003"},{"key":"2025082723203970000_2012.oct22_1.bcr2012007034.7","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa050092"},{"key":"2025082723203970000_2012.oct22_1.bcr2012007034.8","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2010.32.4327"},{"key":"2025082723203970000_2012.oct22_1.bcr2012007034.9","doi-asserted-by":"publisher","DOI":"10.1016\/j.hoc.2009.04.001"},{"key":"2025082723203970000_2012.oct22_1.bcr2012007034.10","doi-asserted-by":"publisher","DOI":"10.1038\/nature00766"},{"key":"2025082723203970000_2012.oct22_1.bcr2012007034.11","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.10186"},{"key":"2025082723203970000_2012.oct22_1.bcr2012007034.12","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2005.04.5344"},{"key":"2025082723203970000_2012.oct22_1.bcr2012007034.13","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1097\/00008390-199812000-00010","article-title":"Phase II study of neoadjuvant concurrent biochemotherapy in melanoma patients with local\u2212regional metastases","volume":"8","author":"Buzaid","year":"1998","journal-title":"Melanoma Res"},{"key":"2025082723203970000_2012.oct22_1.bcr2012007034.14","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1002\/jso.21882","article-title":"Neoadjuvant therapy for high-risk bulky regional melanoma","volume":"104","author":"Tarhini","year":"2011","journal-title":"J Surg Oncol"},{"key":"2025082723203970000_2012.oct22_1.bcr2012007034.15","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-11-1463"},{"key":"2025082723203970000_2012.oct22_1.bcr2012007034.16","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1097\/00000421-199308000-00018","article-title":"Evaluation of cisplatin and DTIC in inoperable stage III and IV melanoma. A Southwest Oncology Group study","volume":"16","author":"Fletcher","year":"1993","journal-title":"Am J Clin Oncol"},{"key":"2025082723203970000_2012.oct22_1.bcr2012007034.17","doi-asserted-by":"crossref","unstructured":"Tarhini A Edington H Butterfield LH . Neoadjuvant ipilimumab in patients with stage IIIB\/C melanoma: immunogenicity and biomarker analysis. 2011 ASCO Annual Meeting. Chicago, IL, USA.","DOI":"10.1200\/jco.2011.29.15_suppl.8536"},{"key":"2025082723203970000_2012.oct22_1.bcr2012007034.18","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1203421"},{"key":"2025082723203970000_2012.oct22_1.bcr2012007034.19","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(12)60398-5"}],"container-title":["BMJ Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bcr-2012-007034","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,28]],"date-time":"2025-08-28T06:20:51Z","timestamp":1756362051000},"score":1,"resource":{"primary":{"URL":"https:\/\/casereports.bmj.com\/lookup\/doi\/10.1136\/bcr-2012-007034"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,10,23]]},"references-count":19,"alternative-id":["10.1136\/bcr-2012-007034"],"URL":"https:\/\/doi.org\/10.1136\/bcr-2012-007034","relation":{},"ISSN":["1757-790X"],"issn-type":[{"type":"electronic","value":"1757-790X"}],"subject":[],"published":{"date-parts":[[2012,10,23]]}}}